Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionBaillie Gifford & Co
Latest Disclosed Ownership440,208 shares
Latest Disclosed Value $ 35,251,857
Baillie Gifford & Co reports 14.74% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 8, 2026 - Baillie Gifford & Co filed a 13F-HR form disclosing ownership of 440,208 shares of Edwards Lifesciences Corporation (MX:EW) valued at $35,251,857 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 516,311 shares of Edwards Lifesciences Corporation. This represents a change in shares of -14.74% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F Edwards Lifesciences COM 28176E108 440,208 -76,103 -14.74 35,252 -19.91 0.0360
2026-01-23 2025-12-31 13F Edwards Lifesciences COM 28176E108 516,311 -55,936 -9.77 44,016 -1.10 0.0366
2025-10-31 2025-09-30 13F Edwards Lifesciences COM 28176E108 572,247 -10,351 -1.78 44,504 -2.33 0.0330
2025-08-06 2025-06-30 13F Edwards Lifesciences COM 28176E108 582,598 1,157 0.20 45,565 8.12 0.0340
2025-05-07 2025-03-31 13F Edwards Lifesciences COM 28176E108 581,441 -125,355 -17.74 42,143 -19.46 0.0368
2025-01-31 2024-12-31 13F Edwards Lifesciences COM 28176E108 706,796 498,100 238.67 52,324 279.96 0.0402
2024-11-05 2024-09-30 13F Edwards Lifesciences COM 28176E108 208,696 -143,607 -40.76 13,772 -57.68 0.0103
2024-07-25 2024-06-30 13F Edwards Lifesciences COM 28176E108 352,303 -44,250 -11.16 32,542 -14.12 0.0254
2024-05-01 2024-03-31 13F Edwards Lifesciences COM 28176E108 396,553 -7,405 -1.83 37,895 23.03 0.0295
2024-01-26 2023-12-31 13F Edwards Lifesciences COM 28176E108 403,958 -36,443 -8.27 30,802 0.95 0.0244
2023-11-13 2023-09-30 13F Edwards Lifesciences COM 28176E108 440,401 -23,639 -5.09 30,511 -30.30 0.0278
2023-07-28 2023-06-30 13F Edwards Lifesciences COM 28176E108 464,040 -3,444 -0.74 43,773 13.18 0.0372
2023-05-03 2023-03-31 13F Edwards Lifesciences COM 28176E108 467,484 31,993 7.35 38,675 19.03 0.0349
2023-03-10 2022-12-31 13F/A-1 Edwards Lifesciences COM 28176E108 435,491 3,345 0.77 32,492 -9.01 0.0339
2023-01-24 2022-12-31 13F Edwards Lifesciences COM 28176E108 435,491 3,345 32 0.0126
2022-10-27 2022-09-30 13F Edwards Lifesciences COM 28176E108 432,146 11,921 2.84 35,708 -10.64 0.0368
2022-08-08 2022-06-30 13F Edwards Lifesciences COM 28176E108 420,225 -5,000 -1.18 39,960 -20.17 0.0410
2022-05-05 2022-03-31 13F Edwards Lifesciences COM 28176E108 425,225 -7,463 -1.72 50,058 -10.70 0.0351
2022-01-20 2021-12-31 13F Edwards Lifesciences COM 28176E108 432,688 11,143 2.64 56,054 17.46 0.0308
2021-10-19 2021-09-30 13F Edwards Lifesciences COM 28176E108 421,545 17,758 4.40 47,723 14.12 0.0250
2021-08-02 2021-06-30 13F Edwards Lifesciences COM 28176E108 403,787 -1,170 -0.29 41,820 23.47 0.0204
2021-05-06 2021-03-31 13F Edwards Lifesciences COM 28176E108 404,957 124,646 44.47 33,871 32.45 0.0189
2021-02-10 2020-12-31 13F Edwards Lifesciences COM 28176E108 280,311 26,830 10.58 25,573 26.39 0.0142
2020-11-12 2020-09-30 13F Edwards Lifesciences COM 28176E108 253,481 58,738 30.16 20,233 50.33 0.0139
2020-08-12 2020-06-30 13F Edwards Lifesciences COM 28176E108 194,743 193,606 17,027.79 13,459 6,189.25 0.0103
2020-05-08 2020-03-31 13F Edwards Lifesciences COM 28176E108 1,137 -119 -9.47 214 -26.96 0.0002
2020-02-10 2019-12-31 13F Edwards Lifesciences COM 28176E108 1,256 0 0.00 293 6.16 0.0003
2019-11-07 2019-09-30 13F Edwards Lifesciences COM 28176E108 1,256 -71 -5.35 276 12.65 0.0003
2019-08-08 2019-06-30 13F Edwards Lifesciences COM 28176E108 1,327 0 0.00 245 -3.54 0.0003
2019-05-01 2019-03-31 13F Edwards Lifesciences COM 28176E108 1,327 0 0.00 254 25.12 0.0003
2019-02-14 2018-12-31 13F Edwards Lifesciences COM 28176E108 1,327 1,327 203 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.